Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes)) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Vasomotor Symptoms of Menopause (Hot Flashes) Overview
  3. Therapeutics Development
  4. Pipeline Products for Vasomotor Symptoms of Menopause (Hot Flashes) - Overview
  5. Pipeline Products for Vasomotor Symptoms of Menopause (Hot Flashes) - Comparative Analysis
  6. Vasomotor Symptoms of Menopause (Hot Flashes) - Therapeutics under Development by Companies
  7. Vasomotor Symptoms of Menopause (Hot Flashes) - Therapeutics under Investigation by Universities/Institutes
  8. Vasomotor Symptoms of Menopause (Hot Flashes) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Vasomotor Symptoms of Menopause (Hot Flashes) - Products under Development by Companies
  13. Vasomotor Symptoms of Menopause (Hot Flashes) - Products under Investigation by Universities/Institutes
  14. Vasomotor Symptoms of Menopause (Hot Flashes) - Companies Involved in Therapeutics Development
  • Amgen Inc.
  • EndoCeutics, Inc.
  • Euroscreen S.A.
  • MenoGeniX, Inc.
  • Mithra Pharmaceuticals S.A.
  • Pherin Pharmaceuticals, Inc.
  • Pivot Pharmaceuticals Inc
  • Radius Health, Inc.
  • TherapeuticsMD, Inc.

For more information visit http://www.researchandmarkets.com/research/92zr7h/vasomotor

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health, Sexual and Reproductive Health Drugs